Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be met...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Load-Dependent Effects of Sodium Glucose Co-Transporter Inhibitors on Work in Human Hypertrophic Cardiomyopathy Living Myocardial Slices.

bioRxiv : the preprint server for biology·2026
Same author

Pathogenic <i>MYBPC3</i> missense variants alter protein-protein interactions within the sarcomere.

bioRxiv : the preprint server for biology·2026
Same author

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026
Same author

Physical Activity in Pediatric Cardiomyopathies: Moving for Health: A Scientific Statement From the American Heart Association.

Circulation·2026
Same author

The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026
Same author

Long non-coding RNA profiling of hypertrophic cardiomyopathy in mice.

Scientific data·2026
Same journal

ChemoCardioNet: An Explainable Multimodal Transformer for Early Prediction of Chemotherapy-Induced Cardiotoxicity.

Journal of cardiovascular translational research·2026
Same journal

Metabolic Heterogeneity Across Heart Failure Subtypes Defined by Integrative Multi-Omics Analysis.

Journal of cardiovascular translational research·2026
Same journal

The Immediate Impact of Infarct Size on the Systemic Inflammatory Response: IL-6 as Central Mediator Identified through Biomarker and Proteomic Profiling.

Journal of cardiovascular translational research·2026
Same journal

Extracellular Vesicles Link Cerebral Ischemia to Coronary Microvascular Dysfunction - Role for RGD Motif-Activated Endothelin Signaling.

Journal of cardiovascular translational research·2026
Same journal

Tracing the pathogenic PLN p.(Arg14del) variant across the globe; more than just a local curiosity.

Journal of cardiovascular translational research·2026
Same journal

Immunometabolic Remodeling in Ischemic and Non-Ischemic Heart Failure.

Journal of cardiovascular translational research·2026
See all related articles

Related Experiment Videos

Exercise in hypertrophic cardiomyopathy.

Sharlene M Day1

  • 1Division of Cardiovascular Medicine, University of Michigan Health System, Ann Arbor, MI, 48109, USA. sday@umich.edu

Journal of Cardiovascular Translational Research
|June 19, 2010
PubMed
Summary
This summary is machine-generated.

Individuals with hypertrophic cardiomyopathy (HCM) face risks during vigorous exercise. Balancing exercise benefits and risks is crucial for managing HCM, with exercise stress testing aiding in patient evaluation and prescription.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Sports Medicine
  • Exercise Physiology

Background:

  • Hypertrophic cardiomyopathy (HCM) poses a significant risk of sudden cardiac death (SCD) during strenuous athletic competition.
  • Guidelines for recreational sports participation in HCM patients are based on expert consensus, providing a framework for patient counseling.

Purpose of the Study:

  • To review the risks and benefits of exercise in individuals with hypertrophic cardiomyopathy (HCM).
  • To discuss the role of exercise stress testing and cardiopulmonary exercise testing in managing HCM patients.
  • To explore the theoretical long-term effects of exercise on HCM pathophysiology.

Main Methods:

  • Review of existing literature on exercise, sudden cardiac death, and hypertrophic cardiomyopathy.
  • Analysis of the diagnostic and prognostic value of exercise stress testing in HCM.
  • Discussion of cardiopulmonary exercise testing applications and animal study findings.

Main Results:

  • Exercise stress testing provides objective measures of functional capacity, hemodynamic responses, ischemia, and outflow tract obstruction in HCM.
  • Cardiopulmonary exercise testing can help establish safe exercise intensity targets for individualized prescriptions.
  • Animal studies suggest voluntary exercise may prevent or reverse pathological features of HCM.

Conclusions:

  • A balance between potential risks and benefits of aerobic fitness is necessary for individuals with HCM.
  • Further research is needed to fully understand the long-term effects of exercise on HCM pathophysiology.
  • Individualized exercise prescriptions, guided by objective testing, are essential for HCM patient management.